Internal Medicine, Nephrology · Los Angeles, CA
NPI
1073747135
Since 2009
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1400 S Grand Ave Ste 800
Los Angeles, CA, 90015
Phone (213) 748-1414
Groups this clinician bills Medicare through
Medicare paid, 2024
$230K
2,040 services
Medicare patients, 2024
406
Average age 66
Drug cost, 2024
$1.0M
1,863 prescriptions
Company payments, 2025
$1,306
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Luani Lee was code 99233 (hospital e&m - subsequent), 376 times for 133 patients. In total Luani Lee billed 2,040 services in 27 codes, and Medicare paid $230K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-11-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 376 | 133 | $97.14 | $37K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 195 | 102 | $12.62 | $2,462 |
| 90960 ESRD Related Services (not dialysis) | Office | 190 | 45 | $292.70 | $56K |
| 99214 Office E&M - Established | Office | 182 | 103 | $81.27 | $15K |
| 99232 Hospital E&M - Subsequent | Facility | 182 | 73 | $64.51 | $12K |
| 90966 ESRD Related Services (not dialysis) | Office | 178 | 25 | $242.33 | $43K |
| 99223 Hospital E&M - Initial | Facility | 140 | 122 | $139.32 | $20K |
| 99457 E&M - Miscellaneous | Office | 108 | 20 | $41.04 | $4,433 |
| 99231 Hospital E&M - Subsequent | Facility | 70 | 37 | $39.41 | $2,759 |
| 99451 E&M - Miscellaneous | Facility | 66 | 63 | $27.98 | $1,847 |
| 90961 ESRD Related Services (not dialysis) | Office | 55 | 35 | $244.55 | $13K |
| 99454 E&M - Miscellaneous | Office | 54 | 14 | $43.25 | $2,336 |
| 99291 Critical Care E&M | Facility | 53 | 28 | $172.39 | $9,137 |
| 99458 E&M - Miscellaneous | Office | 50 | 14 | $33.07 | $1,653 |
| 99213 Office E&M - Established | Office | 38 | 32 | $69.03 | $2,623 |
By year: 2022 $281K for 1,986 services; 2023 $236K for 1,686 services; 2024 $230K for 2,040 services.
Medicare prescription drug claims, 2024
In 2024, the drug Luani Lee prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 161 prescriptions and refills. In total Luani Lee wrote 1,863 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 161 | 213 | 43 | $112K |
| Kerendia Finerenone | 118 | 135 | 17 | $83K |
| Furosemide Generic | 118 | 209 | 48 | $626 |
| Losartan Potassium Generic | 108 | 211 | 48 | $732 |
| Amlodipine Besylate Generic | 105 | 225 | 43 | $553 |
| Jardiance Empagliflozin | 97 | 143 | 37 | $77K |
| Xphozah Tenapanor Hcl | 87 | 91 | 16 | $258K |
| Hydralazine Hcl Generic | 60 | 99 | 18 | $554 |
| Procrit Epoetin Alfa | 56 | 61 | 15 | $42K |
| Sevelamer Carbonate Generic | 54 | 93 | 21 | $17K |
| Famotidine Generic | 46 | 68 | 12 | $233 |
| Lokelma Sodium Zirconium Cyclosilicate | 45 | 51 | 18 | $28K |
| Nifedipine Er Nifedipine | 41 | 102 | 13 | $2,909 |
| Spironolactone Generic | 38 | 62 | Under 11 | $153 |
| Febuxostat Generic | 31 | 45 | Under 11 | $1,784 |
Brand drugs: 714 claims; generic drugs: 1,136 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Luani Lee $1,306 ($1,306 in general payments such as food, travel and fees) from 14 companies. The largest payer was Ardelyx, Inc. with $378.
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. ARDX | 24 | $378 |
| Amgen Inc. AMGN | 20 | $224 |
| GastroKlenz, Inc. DBA CloudCath | 1 | $200 |
| Fresenius USA Marketing, Inc. | 6 | $143 |
| ANI Pharmaceuticals, Inc. ANIP | 3 | $57.53 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $48.81 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $41.31 |
| Vifor Pharma, Inc. | 1 | $34.51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $34.2 |
| Travere Therapeutics, Inc. TVTX | 1 | $34.07 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.